SecBot SecBot
SECBOTREPLAY Home › Report › WGS

WGS · GeneDx CEO Katherine Stueland sold $455K in open-market shares while…

GeneDx Holdings Corp. · CLUSTER filed Mar 3, 2026 at 19:00 ET

At the news

BEARISHIMPACT 6/10

CLUSTER filed Mar 3, 2026 at 19:00 ET

GeneDx CEO Katherine Stueland sold $455K in open-market shares while receiving a large non-cash stock award; CFO Kevin Feeley sold $110K and received non-cash grants. The cluster is dominated by routine compensation grants, but the CEO's open-market sale is the largest transaction and suggests potential lack of conviction.

  • CEO Katherine Stueland sold 5,861 shares at $77.63, totaling $454,967 in open-market transaction
  • CFO Kevin Feeley sold 1,424 shares for $110,540 in open-market trade
  • CEO and CFO received substantial non-cash stock awards totaling 107,469 shares collectively, valued at $299,926 for the CEO's time-based grant
  • Total open-market selling: $565,507 (CEO: $455K, CFO: $110.5K)

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access